Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Short term Debt (2022 - 2024)

Gossamer Bio's Short term Debt history spans 3 years, with the latest figure at $9.6 million for Q1 2024.

  • For Q1 2024, Short term Debt fell 17.43% year-over-year to $9.6 million; the TTM value through Mar 2024 reached $9.6 million, down 17.43%, while the annual FY2023 figure was $11.6 million, 0.0% changed from the prior year.
  • Short term Debt reached $9.6 million in Q1 2024 per GOSS's latest filing, down from $11.6 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $11.6 million in Q4 2022 to a low of $9.6 million in Q1 2024.
  • Average Short term Debt over 3 years is $11.3 million, with a median of $11.6 million recorded in 2022.
  • Peak YoY movement for Short term Debt: changed 0.0% in 2023, then fell 17.43% in 2024.
  • A 3-year view of Short term Debt shows it stood at $11.6 million in 2022, then changed by 0.0% to $11.6 million in 2023, then dropped by 17.43% to $9.6 million in 2024.
  • Per Business Quant, the three most recent readings for GOSS's Short term Debt are $9.6 million (Q1 2024), $11.6 million (Q4 2023), and $11.6 million (Q3 2023).